Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shanjinlian Soft Capsule for Common Cold (Wind-Heat Pattern) Phase II Trial
CTR20223237Phase 2Completed
- Sponsor
- Huanghe Traditional Chinese Medicine
- Start
- Jan 2023
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Shanjinlian in nasopharyngitis, sponsored by Huanghe Traditional Chinese Medicine. Started Jan 2023; status: completed.
02
Drugs
Shanjinlian
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on CTR20223237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20223237.